SCM
CORZ

Saba Capital Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Saba Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,213
Closed -$265K – 798
2021
Q3 		$265K Sell
26,213
-71,323
-73% -$717K 0.01% 484
2021
Q2 		$959K Buy
+97,536
New +$961K 0.03% 368

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Saba Capital Management's CORZ Position: Q4 2021 in Review

Saba Capital Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2021, closing a stake of 26,213 shares — an estimated $265K sold.

Saba Capital Management first reported a position in CORZ in Q2 2021 and held it in 2 quarters. The position peaked at $959K in Q2 2021. 71 funds tracked by Wall St. Rank hold CORZ as of Q4 2021.

  • Saba Capital Management reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Saba Capital Management sold 26,213 Core Scientific, Inc. Common Stock shares in Q4 2021, an estimated $265K.
  • Saba Capital Management first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Saba Capital Management's Core Scientific, Inc. Common Stock position peaked at $959K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2021.

Based on Saba Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.